ストックスクリーナーアプリを入手
0.3555
0.00%
0.00
アフターアワーズ：
.35
-0.0055
-1.55%
前日終値:
$0.3555
開ける：
$0.3537
24時間の取引高:
1.01M
Relative Volume:
0.11
時価総額：
$25.58M
収益：
-
当期純損益:
$-86.08M
株価収益率:
-0.1648
EPS:
-2.1574
ネットキャッシュフロー:
$-72.06M
1週間 パフォーマンス:
+10.99%
1か月 パフォーマンス:
-29.74%
6か月 パフォーマンス:
-72.86%
1年 パフォーマンス:
-61.16%
1日の値動き範囲:
$0.318
$0.358
1週間の範囲:
$0.3042
$0.3977
52週間の値動き範囲:
$0.2053
$2.79
Io Biotech Inc Stock (IOBT) Company Profile
Compare IOBT vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IOBT
Io Biotech Inc
|
0.3555 | 25.58M | 0 | -86.08M | -72.06M | -2.1574 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Io Biotech Inc Stock (IOBT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-26 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2026-01-08 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2025-09-30 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-30 | ダウングレード | TD Cowen | Buy → Hold |
Io Biotech Inc (IOBT) 最新ニュース
Layoff Tracker: Delayed Notice Reveals 141 More Layoffs From Genentech in 2025 - BioSpace
Guidance Update: Is IO Biotech Inc in a consolidation phaseJuly 2025 PostEarnings & Safe Capital Growth Tips - baoquankhu1.vn
Fierce Biotech Layoff Tracker 2026: ARPA-H makes cuts; GSK trims R&D team - Fierce Biotech
IO Biotech Provides Corporate Update - marketscreener.com
IO Biotech, Inc. (NASDAQ:IOBT) Receives Consensus Recommendation of “Reduce” from Analysts - Defense World
IO Biotech (IOBT) launches restructuring, CMO exit and up to $2.6M charges - Stock Titan
IO Biotech hires Raymond James as advisor, cuts workforce By Investing.com - Investing.com Canada
IO Biotech Engages Raymond James as Financial Advisor Amid Workforce Reduction and Cost-Containment Measures - Quiver Quantitative
Cancer vaccine maker IO Biotech cuts staff, hires Raymond James - Stock Titan
Is IO Biotech Inc. a top pick in the sectorWeekly Trend Recap & Daily Volume Surge Signals - mfd.ru
Piper downgrades IO Biotech amid strategic alternatives evaluation - Yahoo Finance
IO Biotech stock tumbles after Piper Sandler downgrades on strategic review By Investing.com - Investing.com South Africa
IO Biotech stock tumbles after Piper Sandler downgrades on strategic review - Investing.com South Africa
Piper Sandler Downgrades IO Biotech (IOBT) to Neutral, Lowers Pr - GuruFocus
Piper Sandler Downgrades IO Biotech to Neutral From Overweight, Adjusts Price Target to $0.50 From $3 - marketscreener.com
IO Biotech Shares Fall After Piper Sandler Downgrade - marketscreener.com
IO Biotech stock rating downgraded by Piper Sandler amid strategic review - Investing.com South Africa
IO Biotech, Inc. (IOBT) Upgraded to Buy: Here's Why - MSN
Aug Decliners: Is IO Biotech Inc a potential multi baggerMarket Growth Report & Entry and Exit Point Strategies - baoquankhu1.vn
IOBT IO Biotech, Inc. (NASDAQ) $0.47 on 22 Jan 2026: active intraday mover for traders - Meyka
IO Biotech’s Future Uncertain As Cylembio Cloud Remains - Citeline News & Insights
IO Biotech Begins Review Of Strategic Options As Cash Runway Narrows - Nasdaq
IO Biotech weighs strategic options months after FDA advises against melanoma vaccine filing - European Biotechnology Magazine
IO Biotech admits defeat | ApexOncoClinical Trials news and analysis - Oncology Pipeline
Listed Danish biotech company fights for survival after FDA rejection and failed capital raising - medwatch.com
IO Biotech (IOBT) Explores Strategic Alternatives, Stock Surges 19.36% - Intellectia AI
Biotech Stocks Surge After Hours: IO Biotech Jumps 19%, Cue Biopharma And Cabaletta Bio Follow - Nasdaq
IO Biotech stock plummets after company explores strategic alternatives By Investing.com - Investing.com Nigeria
IO Biotech stock plummets after company explores strategic alternatives - Investing.com
IO Biotech announces exploration of strategic alternatives - TipRanks
IO mulls more layoffs months after halving head count in wake of cancer vaccine setback - Fierce Biotech
IO Biotech Explores Strategic Alternatives Amid Cost-Cutting Plans - TipRanks
IO Biotech (IOBT) Explores Strategic Alternatives to Maximize Shareholder Value - Intellectia AI
IO Biotech, Inc. Announces Exploration of Strategic Alternatives - TradingView
IO Biotech to explore strategic alternatives - MSN
IO Biotech Announces Exploration of Strategic Alternatives - The Manila Times
IO Biotech Announces Exploration of Strategic Alternatives to Enhance Stockholder Value - Quiver Quantitative
Moderna cancer vaccine holds up; IO Biotech considers a sale - Yahoo Finance
Cancer vaccine developer weighs sale, merger or liquidation - Stock Titan
Merger Talk: Does IO Biotech Inc align with a passive investing strategy2025 Technical Patterns & Verified Swing Trading Watchlist - baoquankhu1.vn
Market Review: How do insiders feel about SOPAWeekly Stock Report & Real-Time Stock Entry Alerts - baoquankhu1.vn
Market Trends: What is the long term forecast for IO Biotech Inc stockJuly 2025 Momentum & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Valuation Update: Can ALCY lead its sector in growthWeekly Trade Recap & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
IO Biotech receives Nasdaq notice for bid price noncompliance - MSN
Jefferies maintains IO Biotech Buy rating, $8 target on PFS hopes - MSN
IO Biotech Faces Existential Threats as Funding and Regulatory Woes Mount - AD HOC NEWS
Aug Shorts: Will IO Biotech Inc outperform tech stocksJuly 2025 Action & Verified Swing Trading Watchlists - baoquankhu1.vn
What margin trends mean for IO Biotech Inc. stockMarket Growth Report & Weekly Setup with High ROI Potential - Bộ Nội Vụ
Sectors Review: Will IO Biotech Inc outperform tech stocks2025 Big Picture & High Conviction Investment Ideas - baoquankhu1.vn
Hedge Fund Moves: Can IO Biotech Inc beat the S P 500GDP Growth & Proven Capital Preservation Tips - baoquankhu1.vn
Published on: 2026-01-10 21:43:17 - Улправда
Io Biotech Inc (IOBT) 財務データ
収益
当期純利益
現金流量
EPS
1.24%
0.19%
大文字化:
|
ボリューム (24 時間):